Search Press releases Keywords From To 30 Dec 2016 Transparency notification Read More 23 Dec 2016 Transparency notification Read More 19 Dec 2016 Transparency notification Read More 19 Dec 2016 UCB and Amgen announce submission of application for investigational osteoporosis medication romosozumab in Japan Read More 19 Dec 2016 UCB’s anti-epileptic drug VIMPAT® (lacosamide) approved as monotherapy by European Commission Read More 15 Dec 2016 Transparency notification Read More Pagination First page Previous page Previous … Page 84 Page 85 Page 86 Page 87 Current page 88 Page 89 Page 90 Page 91 Page 92 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
